1. Rekomendatsii po lecheniyu arterial'noi gipertonii ESH/ESC 2013. Rossiiskii kardiologicheskii zhurnal, 2014, 1(105): 14.
2. Burnier M. Pathophysiological and clinical implications of AT(1) and AT(2) angiotensin II receptors in essential hypertension. Drugs, 2002, 62(1): 21-29.
3. Dzau V et al. Heterogenity of angiotensin synthetic pathways and receptor subtypes: physiological and pharmacological implications. J. Hypertens., 1993, 11(3): 11–18.
4. Jackson EK, Garrison JC: Renin and Angiotensin. In Goodman & Gilman’s The Pharmacological Basis of Therapeutics. 10th edition. New York: McGraw Hill, 2003: 744.
5. Bova A.A. Mesto antagonistov retseptorov angiotenzina II v klinicheskoi praktike. Meditsinskie novosti, 2009, 6: 11-15.